Pelagia Tsoutsou

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


13 publications

2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2012 |
2021
Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy.
Chmielewski-Stivers N., Petit B., Ollivier J., Monceau V., Tsoutsou P., Quintela Pousa A., Lin X., Limoli C., Vozenin M.C., 2021/08/06. Cancers, 13 (16) p. 3973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC36C22A988A]
2020
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
Belkacemi Y., Grellier N., Ghith S., Debbi K., Coraggio G., Bounedjar A., Samlali R., Tsoutsou P.G., Ozsahin M., Chauvet M.P. et al., 2020/08. European journal of cancer, 135 pp. 130-146. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_781F39A88B91]
2019
 
"Shared Decision Making Is the Gold Standard"!
Tsoutsou P.P., Belkacemi Y., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 12-13. Peer-reviewed.
[DOI][Pmid][serval:BIB_E1FEA7743FE3]
 
Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?
Belkacemi Y., Majdoul S., Tsoutsou P.P., Abouegylah M., Kaidar-Person O., Meattini I., Poortmans PMP, Taghian A., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 10-11. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82F32C7C404E]
 
AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).
Todorovic V., Aapro M., Pavlidis N., Arsovski O., Belkacemi Y., Babovic N., Bidard F.C., Bourhafour M., Beslija S., Boussen H. et al., 2019. Journal of B.U.ON., 24 (5) pp. 2180-2197. Peer-reviewed.
[WoS][Pmid][serval:BIB_E0EBE7F4B7A3]
 
Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer.
Tsoutsou P.G., Vozenin M.C., 2019/01/01. JAMA oncology, 5 (1) pp. 111-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1030AE5EA05]
2018
 
A need for biology-driven personalized radiotherapy in breast cancer.
Tsoutsou P.G., Durham A.D., Vozenin M.C., 2018/01. Breast cancer research and treatment, 167 (2) pp. 603-604. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_26EEF7E656C6]
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.
Tsoutsou P.G., Zaman K., Martin Lluesma S., Cagnon L., Kandalaft L., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 609. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F237867AE06]
2017
 
TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.
Tsoutsou P., Annibaldi A., Viertl D., Ollivier J., Buchegger F., Vozenin M.C., Bourhis J., Widmann C., Matzinger O., 2017/05. Radiation research, 187 (5) pp. 562-569. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13F935643BF3]
 
Abstract P6-09-52: Prognostic factors in breast cancer (BC) associated with the development of brain metastases (BM): A retrospective study of 726 pts
Santa Cruz O, Tsoutsou P, Anchisi S, Khanfir K, Negretti L, Girardet C, Ozsoy O, Ozsahin M, 2017/02/15., San Antonio Breast Cancer Symposium pp. P6-09-52-P6-09-52 dans Cancer Research, American Association for Cancer Research (AACR).
[DOI][WoS][serval:BIB_14F6EEDDA1DE]
 
How could breast cancer molecular features contribute to locoregional treatment decision making?
Tsoutsou P.G., Vozenin M.C., Durham A.D., Bourhis J., 2017/02. Critical reviews in oncology/hematology, 110 pp. 43-48. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3744B53511C]
2015
 
Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?
Tsoutsou P.G., Bourhis J., Coukos G., 2015. Journal of Clinical Oncology, 33 (11) pp. 1297-1298. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DCE380A0052]
2012
 
Response to "Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy." (Int J Radiat Oncol Biol Phys 2011;80:398-402).
Tsoutsou P.G., Jeanneret Sozzi W., Ozsahin M., 2012. International Journal of Radiation Oncology, Biology, Physics, 82 (2) p. 519.
[DOI][WoS][Pmid][serval:BIB_127225E3B7E4]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University